| Revenue growth | 9% YoY for Q4 FY26; flat for full year FY26. |
|---|---|
| Margins | Gross margins resilient at 69.6%; EBITDA margins at 31.2% (FY26). |
| Demand visibility | Urban markets picking up; rural markets converging and showing stabilization. |
| Management confidence | High optimism for 2026 driven by premiumization elasticity. |
Growth
Q4 domestic sales grew 9.2%; full-year FY26 revenue was flat. EBITDA margin at 31.2% for FY26.
Outlook
Interim dividend of Rs. 48 declared. Management aims for balanced volume/price growth and continuous premiumization (35% growth mix).
Risks
Headwinds from commodity costs, currency volatility, and inverted duty structure impact on margins (160 bps in Q4).
Earnings Call filed with BSE, NSE: COLPAL. Summary written with AI assistance from the document.
Colgate-Palmolive (India) Ltd: key numbers
- Share price
- ₹1,809.40
- Market cap
- ₹49,213 Cr
- Revenue (annual)
- ₹6,035 Cr
- Net profit (annual)
- ₹1,325 Cr
- P/E (TTM)
- 36.5×Sector 42.5×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 13.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colgate-Palmolive (India) Ltd
All →Colgate-Palmolive (India) Business Update
Colgate-Palmolive (India) has partnered with Kaun Banega Crorepati Season 18 to integrate oral health awareness messages into the show's daily narrative through unique celebrity sign-offs.
Colgate-Palmolive (India) Management Change
Colgate-Palmolive (India) Limited announced the resignation of Mr. G. Ramprasad as its Internal Auditor, effective August 31, 2026, to explore other opportunities.
Colgate-Palmolive (India) Earnings Call Transcript: Key Takeaways
Colgate-Palmolive (India) reported Q1 sales of Rs. 1591 crores, a 12% increase. Strategy focuses on driving oral care consumption and premiumisation, with premium segments growing 5X faster than competitors.
Colgate-Palmolive (India) Management Change
Colgate-Palmolive (India) announced the resignation of MD & CEO Prabha Narasimhan, effective September 27, 2026. Manish Anandani succeeds her as MD & CEO effective September 28, 2026.
Colgate-Palmolive (India) Business Update
Colgate-Palmolive's PerioGard portfolio became India's first gum care regimen to earn the Indian Society of Periodontology's (ISP) Seal of Acceptance for its clinical standards.
Colgate-Palmolive (India) Investor Presentation: Key Takeaways
Colgate India reported robust Q1 FY27 net sales growth of 12% YoY, accelerating from 9% in the previous quarter. The company is focused on category growth through premiumization and expanding rural toothbrush penetration.